Similar articles

• Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?

  Afiadata A, Ellsworth P. Afiadata A, et al. Hosp Pract (1995). 2014 Dec;42(5):69-82. doi: 10.3810/hp.2014.12.1160. Hosp Pract (1995). 2014. PMID: 25485919 Review.
• Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function.

  Golan R, Scovell JM, Ramasamy R. Golan R, et al. Aging Male. 2015;18(3):201-4. doi: 10.3109/13685538.2015.1052392. Epub 2015 Jun 15. Aging Male. 2015. PMID: 26075536 Free PMC article. Review.
• [Therapy of the "aging male"].

  Diemer T, Hauck EW, Rohde V, Weidner W. Diemer T, et al. Urologe A. 2005 Oct;44(10):1173-8. doi: 10.1007/s00120-005-0906-5. Urologe A. 2005. PMID: 16151757 Review. German.
• Hypotestosteronaemia in the aging male: should we treat it?

  Christe N, Meier CA. Christe N, et al. Swiss Med Wkly. 2015 Nov 24;145:w14216. doi: 10.4414/smw.2015.14216. eCollection 2015. Swiss Med Wkly. 2015. PMID: 26599486 Review.
• Testosterone replacement therapy: For whom, when and how?

  Tsametis CP, Isidori AM. Tsametis CP, et al. Metabolism. 2018 Sep;86:69-78. doi: 10.1016/j.metabol.2018.03.007. Epub 2018 Mar 9. Metabolism. 2018. PMID: 29530796 Review.